[3-(Acetyloxymethyl)-5-hydroxy-4-oxo-6-propan-2-ylcyclohex-2-en-1-yl] 2-methylbut-2-enoate

Details

Top
Internal ID 3eed97e0-68f2-4284-a2e0-b0fda90d9cf9
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Monoterpenoids > Menthane monoterpenoids
IUPAC Name [3-(acetyloxymethyl)-5-hydroxy-4-oxo-6-propan-2-ylcyclohex-2-en-1-yl] 2-methylbut-2-enoate
SMILES (Canonical) CC=C(C)C(=O)OC1C=C(C(=O)C(C1C(C)C)O)COC(=O)C
SMILES (Isomeric) CC=C(C)C(=O)OC1C=C(C(=O)C(C1C(C)C)O)COC(=O)C
InChI InChI=1S/C17H24O6/c1-6-10(4)17(21)23-13-7-12(8-22-11(5)18)15(19)16(20)14(13)9(2)3/h6-7,9,13-14,16,20H,8H2,1-5H3
InChI Key UOJDYMLVAJQOPR-UHFFFAOYSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C17H24O6
Molecular Weight 324.40 g/mol
Exact Mass 324.15728848 g/mol
Topological Polar Surface Area (TPSA) 89.90 Ų
XlogP 1.90
Atomic LogP (AlogP) 1.57
H-Bond Acceptor 6
H-Bond Donor 1
Rotatable Bonds 5

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of [3-(Acetyloxymethyl)-5-hydroxy-4-oxo-6-propan-2-ylcyclohex-2-en-1-yl] 2-methylbut-2-enoate

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9678 96.78%
Caco-2 + 0.6881 68.81%
Blood Brain Barrier + 0.5500 55.00%
Human oral bioavailability - 0.6857 68.57%
Subcellular localzation Mitochondria 0.8997 89.97%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8748 87.48%
OATP1B3 inhibitior + 0.9378 93.78%
MATE1 inhibitior - 0.8400 84.00%
OCT2 inhibitior - 0.8500 85.00%
BSEP inhibitior + 0.7393 73.93%
P-glycoprotein inhibitior - 0.6011 60.11%
P-glycoprotein substrate - 0.8262 82.62%
CYP3A4 substrate + 0.5355 53.55%
CYP2C9 substrate - 0.5918 59.18%
CYP2D6 substrate - 0.9042 90.42%
CYP3A4 inhibition - 0.9249 92.49%
CYP2C9 inhibition - 0.6669 66.69%
CYP2C19 inhibition - 0.7442 74.42%
CYP2D6 inhibition - 0.7208 72.08%
CYP1A2 inhibition - 0.7533 75.33%
CYP2C8 inhibition - 0.8897 88.97%
CYP inhibitory promiscuity - 0.8353 83.53%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 0.7261 72.61%
Carcinogenicity (trinary) Non-required 0.7249 72.49%
Eye corrosion - 0.9706 97.06%
Eye irritation - 0.8901 89.01%
Skin irritation - 0.6452 64.52%
Skin corrosion - 0.9643 96.43%
Ames mutagenesis + 0.5100 51.00%
Human Ether-a-go-go-Related Gene inhibition - 0.4442 44.42%
Micronuclear - 0.6626 66.26%
Hepatotoxicity + 0.5890 58.90%
skin sensitisation - 0.5942 59.42%
Respiratory toxicity + 0.5556 55.56%
Reproductive toxicity - 0.5000 50.00%
Mitochondrial toxicity - 0.7750 77.50%
Nephrotoxicity + 0.6315 63.15%
Acute Oral Toxicity (c) III 0.5657 56.57%
Estrogen receptor binding - 0.5520 55.20%
Androgen receptor binding - 0.6921 69.21%
Thyroid receptor binding - 0.6664 66.64%
Glucocorticoid receptor binding - 0.5154 51.54%
Aromatase binding - 0.6885 68.85%
PPAR gamma - 0.7097 70.97%
Honey bee toxicity - 0.8039 80.39%
Biodegradation - 0.7500 75.00%
Crustacea aquatic toxicity - 0.6900 69.00%
Fish aquatic toxicity + 0.9792 97.92%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 96.68% 96.09%
CHEMBL2581 P07339 Cathepsin D 96.15% 98.95%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 89.39% 94.45%
CHEMBL3060 Q9Y345 Glycine transporter 2 87.20% 99.17%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 85.58% 91.11%
CHEMBL253 P34972 Cannabinoid CB2 receptor 84.69% 97.25%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 84.68% 95.56%
CHEMBL340 P08684 Cytochrome P450 3A4 82.61% 91.19%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Sphaeranthus suaveolens

Cross-Links

Top
PubChem 163048801
LOTUS LTS0208564
wikiData Q105276403